Kiho Chang Min Ahn Immunoforge Inc Fda Ind Stati Uniti Silver Spring Orphan Drug Designation For Pf1801 Us News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Min Ahn, Kiho Chang), a company specializing in developing new drugs for rare musculoskeletal diseases, has reported that their new drug candidate PF1801 which is in development for treatment of Duchenne . .